Sorry, Lea's wasn't basing my observation on opinion. This is a BB after all, but facts that I believe are justifying the my comment/situation:
1) Cancer Drug trials results due soon ( no negative comments from board). Positive results from initial trials. 2) IMM have addressed weaknesses in the perception of the product. a) The re-assertion from CNRS on Lupozor. b) Buyin from a respected scientific board for Lupozor c) Progression on selecting the review board and scientific credentials (supporting Lupozor as a product) d) FDA approval for fast tract (supporting point one and product)
3) Focus on geography & partners, and lack of bandwidth within the company being addressed by engaging a specialised 3rd party for Lupuzor partnership. 4) Institutional investors taking up a position within the company 5) Board's update that we anticipate news shortly.
So basically this is the basis for my comments at the moment, but sure you are aware of all of the above.
resisting the urge to respond on the SCLP bb. All the information that investors need is on the company's website. All the R&D and lead compounds. I also agree with your comments about the 'tone' of the chat on that bb. Some investors like to discuss their shares. Contrary views over there are met with intimidation. What did Harry Enfield say in one of those sketches. ' I am more intelligent than you' If I need to do more research in order to ramp this company then I should consider whether or not I should have invested in the first place. The only reason I am not invested over SCLP is not because of 'tone' but because having 2 companies in the same sector does not fit into my trading strategy. imo one is not better than the other. However, some investors will read some comments over there and come to only one conclusion. C7 is the perfect gent, cannot see newbies being intimidated by him when asking a straightforward question.
It's just my view on things and WH confirming II's buying or increasing positions. Pi's out of boredom will be selling as they see quick gains elsewhere. I think it is the 'nature of the business' investing in companies such as IMM. Timeframes are difficult to judge, but when this starts to roll it will be very difficult to buy in any worthwhile quantities. The silence from the BoD is deafening to me. Tight-lipped for a reason?
Another thought and more important than any profits here, I hope IMM bring this to the market soon. Many out there that suffer on the affects of Lupus may have an alternative treatment. Lupuzor could be the answer, the delay to them is worse than anyone invested here and bored of waiting.
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.